Search

Background: Tackling the high non-communicable disease (NCD) burden among Syrian refugees poses a challenge to humanitarian actors and host countries. Current response priorities are the identification and integration of key interventions for NCD care into humanitarian programs as well as sustainable financing. To provide evidence for effective NCD intervention planning, we conducted a cross-sectional survey among non-camp Syrian refugees in northern Jordan to investigate the burden and determinants for high NCDs prevalence and NCD multi-morbidities and assess the access to NCD care. Methods: We used a two-stage cluster design with 329 randomly selected clusters and eight households identified through snowball sampling. Consenting households were interviewed about self-reported NCDs, NCD service utilization, and barriers to care. We estimated the adult prevalence of hypertension, diabetes type I/II, cardiovascular- and chronic respiratory conditions, thyroid disease and cancer and analysed the pattern of NCD multi-morbidities. We used the Cox proportional hazard model to calculate the prevalence ratios (PR) to analyse determinants for NCD prevalence and logistic regression to determine risk factors for NCD multi-morbidities by calculating odds ratios (ORs). Results: Among 8041 adults, 21.8%, (95% CI: 20.9–22.8) suffered from at least one NCD; hypertension (14.0, 95% CI: 13.2–14.8) and diabetes (9.2, 95% CI: 8.5–9.9) were the most prevalent NCDs. NCD multi-morbidities were reported by 44.7% (95% CI: 42.4–47.0) of patients. Higher age was associated with higher NCD prevalence and the risk for NCD-multi-morbidities; education was inversely associated. Of those patients who needed NCD care, 23.0% (95% CI: 20.5–25.6) did not seek it; 61.5% (95% CI: 54.7–67.9) cited provider cost as the main barrier. An NCD medication interruption was reported by 23.1% (95% CI: 20–4-26.1) of patients with regular medication needs; predominant reason was unaffordability (63.4, 95% CI: 56.7–69.6). Conclusion: The burden of NCDs and multi-morbidities is high among Syrian refugees in northern Jordan. Elderly and those with a lower education are key target groups for NCD prevention and care, which informs NCD service planning and developing patient-centred approaches. Important unmet needs for NCD care exist; removing the main barriers to care could include cost-reduction for medications through humanitarian pricing models. Nevertheless, it is still essential that international donors agencies and countries fulfill their commitment to support the Syrian-crisis response. [ABSTRACT FROM AUTHOR]

Introduction: While most children experience mild coronavirus disease 2019 (COVID-19) infections, a minority of cases progress to severe or critical illness. This study aimed to assess the efficacy and safety of Remdesivir (RDV) therapy in children with moderate to severe COVID-19, enhancing clinical decision-making and expanding our understanding of antiviral treatments for pediatric patients.Methods: The study included 60 patients, 38 receiving RDV treatment and 22 serving as the control group. Data was collected retrospectively from January 2021 to January 2022 through electronic hospital records.Results: Regarding the main clinical symptoms reported, most patients experienced Upper Respiratory Tract Infections (93.3%), indicating respiratory involvement. Additional symptoms included Central Nervous System (11.7%) and Gastrointestinal (10.0%). Among the 38 cases in the RDV group included in the study, the adverse effects associated with using RDV: Hypoalbuminemia in 19 cases (50.0%) and anemia in 18 cases (47.4%), making them the most common adverse effects. Only one case in the RDV group experienced non-RDV-related death with a different clinical diagnosis. The results showed that RDV treatment was well-tolerated in pediatric patients, with no significant differences in hospital stay and oxygen treatment compared to the control group with P values (0.2, 0.18), respectively.Conclusion: The outcomes indicate that Remdesivir may represent a safe and therapeutic choice for children with coronavirus disease 2019 (COVID-19). [ABSTRACT FROM AUTHOR]

Chronic myeloid leukemia (CML) respond dramatically to molecular target therapy; imatinib (IM), a first generation tyrosine kinase inhibitor (TKIs). Quantitation of cytokines like Interleukin-6, Interleukin-7 and Transforming growth factor-α plasma levels before IM therapy, could assess early molecular response (EMR) to IM and predict imatinib failure. A case-control study of 30 CML patients and 30 controls. Levels of IL-6, IL-7 and TGF-α were assayed by ELISA (R&D systems, USA) for both controls and patients. The patients' BCR-ABL1 transcript was assayed by real time-quantitative polymerase chain reaction, using ipsogen® BCR-ABL1 Mbcr Kit on the Rotor-Gene Q MDx (Qiagen, USA). Cytokines and BCR-ABL1 levels were done both before therapy and at 3 months follow up. Three months following IM therapy, the patients were divided into improved (n= 27) and non-improved (n= 3) groups; based on the establishment of EMR. Plasma levels of IL-7, IL-6 and TGF-α were significantly higher in CML patients (p< 0.05). Cytokines plasma levels dropped significantly after IM therapy (p< 0.05). Correlation studies revealed a strong positive correlation between pretreatment levels of both IL-6 and TGF-α and posttreatment levels of BCR-ABL transcript (r= 0.89 and 0.84, respectively). IL-7 showed a poor correlation with posttreatment levels of BCR-ABL transcript (r= 0.32). Our study revealed a possible role of IL-6, IL-7 and TGF-α as mediators of CML. The initial high levels of IL-6 and TGF-α was associated with the failure of achieving EMR. The initial high levels of IL-7 in CML patients appears to facilitate the disease process. [ABSTRACT FROM AUTHOR]

Improving mortar shielding properties to preserve environmental and human safety in radiation facilities is essential. Conventional cement mortars, composed of cement, water, and lime aggregate, are crucial for radiation shielding. Using recycled aggregates to produce new mortar and concrete compositions has attracted the attention of several researchers. In the current study, waste marble and iron slag as aggregates are used to create novel cement mortar compositions to study the aggregate's impact on the radiation attenuation capability of the mortar. Three mortar groups, including a control mortar (CM-Ctrl), were prepared based on cement and waste marble. The other two groups (CM-MIS, CM-NIS), contained 25% iron slag at different particle sizes as a replacement for a waste marble. The study aims to compare iron slag in their micro and nano sizes to discuss the effect of particle size on the mortar radiation capability. For this purpose, the NaI scintillation detector and radioactive point sources (241Am, 133Ba, 137Cs, 60Co, and 152Eu) were utilized to measure several shielding parameters, such as the linear attenuation coefficient (LAC), mass attenuation coefficient (MAC), half-value layer (HVL), tenth-value layer (TVL), and mean free path (MFP), for the produced mortars at different photon energies. Furthermore, the transmission electron microscope (TEM) is used to measure the particle size of the aggregates. In addition, a scanning electron microscope (SEM) is utilized to acquire the cross-section morphologies of the prepared mortars. According to our findings, mortars prepared with nano-iron slag and waste marble offered superior shielding capabilities than mortars containing natural sand or fine crushed stone. The nano iron slag mortar can be utilized in place of typical sand mortar for applications as rendering or plastering materials for building medical diagnostic and CT scanner rooms, due to its improved shielding abilities. [ABSTRACT FROM AUTHOR]

Background: Drug-related problems (DRPs) are frequent among cancer patients and can have a poor influence on the quality of life (QoL), and increase morbidity as well as mortality. Aim of the work: This study aimed to assess the impact of clinical pharmacist-implemented prescriber’s education on the prevalence of DRPs and patients’ QoL. Patients and Methods: A cross-sectional, 3 phases interventional study (pre-education phase, education phase, and post-education phase) was conducted between May 2018 and May 2020. Prescriptions and filled QoL questionnaires were collected for 500 patients in pre-education and 500 patients' post-education phases from Cairo University National Cancer Institute (Cairo, Egypt) and Assiut University Hospital (Assiut, Egypt). The QoL for each patient was assessed using the Arabic version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ C30 QoL questionnaire. Results: Following clinical pharmacist education, the total number of DRPs in the post-education phase significantly decreased by 43.14 % (p<0.0001) compared to the pre-education phase. The acceptance rate of prescribers was 88.6% to the recommendations done by the clinical pharmacist. Comparing EORTC QLQ C30 questionnaire scores in pre- and post-education phases, there was a statistically significant improvement with fewer problematic patients in the global health status, functional, and symptom scales in the post-education phase. Conclusion: Pharmacist interventions can potentially minimize the incidence of DRPs and are associated with improvement of QoL scores which highlights the importance of the clinical pharmacist's role in cancer care. [ABSTRACT FROM AUTHOR]

Background: Oral potentially malignant lesions (OPML) are suspicious lesions that may turn into malignancy according to the degree of dysplasia. Early diagnosis of these lesions allows their treatment before malignant transformation. Saliva is a liquid biopsy that can be obtained easily from the patient and assessed for biomarkers expression. Our study aimed to investigate the possibility of using salivary and serum TNF-α and Ki-67 in early detection of OPML. Patients with OPML were selected according to histopathological evaluation of the suspected lesions. The lesions were stained immunohistochemically by tumor necrosis factor alpha (TNF-α) and Ki-67. Saliva and blood samples were collected from the patients for detecting the expression of the markers by ELISA. Results: The level of TNF-α and Ki-67 was higher in patients with OPML than healthy individuals regarding both saliva and serum. TNF-α was significantly higher in saliva than in serum unlike Ki-67 which was insignificantly higher in saliva than in serum. The OPML show negative expression of TNF-α in OPML immunohistochemically unlike Ki-67 which show intense positive expression in OPML immunohistochemically. Conclusions: Saliva can be used as an early noninvasive biomarker detector depending on selecting the appropriate salivary biomarker. Salivary TNF-α can be used in early diagnosis of OPML. [ABSTRACT FROM AUTHOR]

Mature B-cell non-Hodgkin lymphoma (B-NHL) occurs due to uncontrolled B-lymphocyte clonal expansion. Cytokines can directly stimulate B-cell proliferation and prevent B-cell apoptosis. Dysregulation of cytokines may play an important role in the development of B-NHL by enhancing chromosomal translocation, which is the hallmark of B-NHL. Both interleukin 2 and tumor necrosis factor-α are proinflammatory cytokines and play important roles in the growth, differentiation, and apoptosis of B cells.We conducted a prospective case-control study applied to 50 patients with B-NHL at Kasr Al Aini Hospital, Cairo University, and 50 age- and sex-matched controls. Clinical, laboratory and imaging data were collected. In all patients and controls, sIL-2R and sTNF-R2 levels were measured by enzyme-linked immunosorbent assay (ELISA). The Spearman correlation test was used to evaluate the correlation between the studied cytokines and clinical, laboratory and imaging findings. Sensitivity analysis was conducted to detect the cutoff values of the studied cytokines.Serum levels of sIL-2R and sTNF-R2 were significantly higher in patients than in controls. Additionally, their levels were significantly higher in aggressive types and advanced stages of lymphoma. Also, the studied cytokines were significantly correlated with different clinical and laboratory parameters of lymphoma. The level of sIL-2R and sTNF-R2 were closely related to the type of lymphoma (P value ˂ 0.001 and 0.012, respectively), further it was also associated with the natural history of lymphoma (aggressive vs. indolent) (P value ˂0.001 and 0.04 respectively).We concluded that Pretreatment levels of sIL-2R and sTNF-R2 may play a role in the natural history and prognosis of lymphoma. They may be used as a prognostic factor for B-NHL patients and may also help with treatment decisions. [ABSTRACT FROM AUTHOR]

Background Asthma is a chronic inflammatory airway disease characterized by episodic reversible airway obstruction. Regarding asthma pathogenesis, two eotaxin polymorphisms were found to be associated with asthma and high serum total immunoglobulin (Ig)E levels, correspondingly. Objective This study was done to explore the association between the underlying gene polymorphisms in chemokine receptor 3 (CCR3) and symptom-based clinical asthma phenotypes among the studied group. Patients and methods This was a case-control study conducted on 60 asthmatic patients with different clinical phenotypes who were compared with 100 healthy controls of matched age and sex. The included asthmatic children aged from 6 to 16 years old and were diagnosed according to the criteria of GINA 2020 by the presence of typical asthma symptoms and with confirmed variable expiratory airflow obstruction. We excluded asthmatic patients with comorbidities. Results A total of 60 asthmatic cases with different clinical phenotypes were compared with 100 healthy controls, and the outcomes showed that total serum IgE had a significant increase in asthmatic cases versus controls. There were no statistically significant differences regarding CCR3 T51C genotype or its allelic polymorphism frequency. There was no clinical significance found correlating eosinophilic percent and serum IgE and CCR3 T51C gene polymorphism in both asthmatic cases and control. There was no statistical significance correlating eosinophilic count, eosinophilic percent, and total serum IgE with different clinical asthma phenotypes. Conclusion Total serum IgE was demonstrated to be significantly increased among asthmatic cases; however, there were no statistically significant differences regarding CCR3 T51C genotype or its allelic polymorphism frequency. Eosinophilic percent and serum IgE and CCR3 T51C gene polymorphism seemed to be comparable among asthmatic cases and controls. Moreover, no significant correlation was detected associating eosinophilic count, eosinophilic percent, and total serum IgE with different clinical asthma phenotypes. [ABSTRACT FROM AUTHOR]

This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb.This experiment was carried out to investigate the effect of feeding low protein diets (~20BFd20.13; ~22BFd22.20; ~24BFd24.32, and ~26BFd26.44) in the presence of the biofloc on the growth performance and feed utilization of (Fenneropenaeus indicus) in comparison with commercial feed of 35% CP as control. The present study was based on application of genetic, nutritional and pathological tools. The biofloc was developed in the low protein diet using molasses as a carbon source. Fifty juveniles F. indicus with an average body weight of 0.52 ± 0.03 g were stocked in 50 L plastic tanks. Low protein diets and the control were tested in three replicates over a 112 days feeding trial. There were significant differences in protein, amino acids profile, lipids and fatty acids profile between the control and low diets group in the presence of the biofloc. However, less variation was noticed in the whole body composition (protein, amino acid profile, lipids and fatty acid profiles) of the shrimp between the control and low diets groups in the presence of the biofloc. There were no significant differences in final weight between control and low diets groups. Same trend was noted in the SGR, which did not vary significantly between low protein diets and control. However, the utilization of the biofloc by shrimp as a feed source was evident by the significant differences (P< 0.05) in FCR between low protein diets and control. There was a significant difference in the shrimp survival (%) (P< 0.05) between the low protein diets and the control which ranged between 86.66 % and 66.66 %, respectively. The development of biofloc significantly reduced the TAN, nitrate NO3-N and nitrite NO2-N levels in the low protein diets tanks. Diagnostic of mortality cases revealed that biofloc can serve as a biosecurity system for shrimp farmimg. RAPD-PCR were used to study the epidemiology of Vibrio parahaemolyticus responsible for early mortality syndrome (EMS) isolated from the water of culture system. The OPC5 (GATGACCGCC) primer produced bands ranged from 1 to 8 with sizes from 0.2–5.0 kb. [ABSTRACT FROM AUTHOR]

In metastatic breast cancer (MBC), the conventional doxorubicin (DOX) has various problems due to lack of selectivity with subsequent therapeutic failure and adverse effects. DOX- induced cardiotoxicity is a major problem that necessitates the presence of new forms to decrease the risk of associated morbidity. Nanoparticles (NPs) are considered an important approach to selectively increase drug accumulation inside tumor cells and thus decreasing the associated side effects. Tumor cells develop resistance to chemotherapeutic agents through multiple mechanisms, one of which is over expression of efflux transporters. Various NPs have been investigated to overcome efflux mediated resistance. To date, only liposomal doxorubicin (LD) and pegylated liposomal doxorubicin (PLD) have entered phase II and III clinical trials and FDA- approved for clinical use in MBC. This review addresses the effects of LD and PLD on the hematological and palmar-plantar erythrodysesthesia (PPE) in anthracycline naïve and pretreated MBC patients. For evidence, studies to be included in this review were identified through PubMed, Cochrane and Google scholar databases. The results derived from: four phase III clinical trials that compared LD with the conventional DOX in naïve MBC patients, and ten non-comparative clinical trials investigated LD and PLD as monotherapy or combination in pretreated MBC. This work confirmed the cardiac tolerability profile of LD and PLD versus DOX, while hematological and skin toxicities were more common. Other DOX-NPs in preclinical trials were discussed in a chronological order. Finally, the modern preclinical development framework for DOX includes exosomal DOX (exo-DOX). Exosomal NPs are non-toxic, non-immunogenic, and can be engineered to have high cargo loading capacity and targeting specificity. These NPs have not been investigated clinically. Our study shows that the full clinical potentiality of DOX-NPs remains to be addressed to move the field forward. [ABSTRACT FROM AUTHOR]

• New lap splicing technique for tensile steel bars has been developed. • The developed technique was based on anchor-ended bars using steel end plats. • Experimental tests confirm the adequacy of the adopted technique under the effect of repeated loading. • Based on the findings of the numerical simulation, a proposed equation was obtained to predict the ultimate splice strength of the anchor-ended bars. In the current paper, a newly developed technique in tension lap splices of steel bars is presented and investigated to verify its efficiency. Consequently, an experimental and numerical study on sixteen high-performance concrete (HPC) specimens containing lap splices without confining reinforcement were performed. The experimental program comprised two phases; the first one was a preliminary study that involved concrete prisms containing the developed splices and tested under axial tension, while the second phase was four-point flexural testing of RC beams having the adopted tension splices and subjected to repeated loading. Both phases included two sub-groups; a reference sub-group having conventional straight-ended splices and the other sub-group implicated in the newly developed technique based on anchor-ended splices. Experimental tests showed that by applying the developed technique, not only higher tensile stress at failure was achieved but also a bond-induced failure was switched to a flexural failure. Furthermore, a splice length of five times bar diameter was found to be sufficient to achieve the full tensile strength of the reinforcing steel bars in the case of the anchor-ended technique. Finally, numerical modeling was employed to study further parameters about the anchor-ended splices. As a result, a proposed equation was obtained based on statistical analysis to predict the ultimate strength of the anchor-ended splice. [ABSTRACT FROM AUTHOR]

Abstract: The corrosion inhibition of Al and its two copper alloys are the subject of tremendous technological importance due to the increased industrial applications of these materials. This paper reports the results of potentiodynamic polarization and electrochemical impedance spectroscopic (EIS) measurements on the corrosion inhibition of Al (Al–2.5% Cu and Al–7.0% Cu) alloys in 1.0M H2SO4 solution carried out in different concentrations of linear-sodium dodecyl benzene sulfonate as an anionic surfactant (LAS) and temperature range from 10 to 60°C. The data revealed that the inhibition efficiency increases with increasing surfactant concentration and time of immersion, and decreases with solution temperature. Energy dispersion X-ray (EDX) observations of the electrode surface confirmed the existence of LAS adsorbed film on the electrode surface. The surfactant acted mainly as cathodic inhibitor. Maximum inhibition efficiency of the surfactant is observed at concentration around its critical micelle concentration (CMC). The inhibition occurs through adsorption of the surfactant on the metal surface without modifying the mechanism of the corrosion process, which tested by UV-spectroscopy. The potential of zero charge (PZC) of aluminum and Al–7.0% Cu was studied by ac-impedance, and the mechanism of adsorption is discussed. The adsorption isotherm is described by Temkin adsorption isotherm. Thermodynamic functions for activation and adsorption process were determined. [Copyright &y& Elsevier]

Abstract: The influence of various concentrations of NaClO4, as a pitting corrosion agent, on the corrosion behaviour of pure Al, and two Al–Cu alloys, namely (Al+2.5wt% Cu) and (Al+7wt% Cu) alloys in 1.0M Na2SO4 solution was investigated by potentiodynamic polarization and potentiostatic techniques at 25°C. Measurements were conducted under the influence of various experimental conditions, complemented by ex situ energy dispersive X-ray (EDX) and scanning electron microscopy (SEM) examinations of the electrode surface. In free perchlorate sulphate solutions, for the three Al samples, the anodic polarization exhibits an active/passive transition. The active dissolution region involves an anodic peak (peak A) which is assigned to the formation of Al2O3 passive film on the electrode surface. The passive region extends up to 1500mV with almost constant current density (j pass) without exhibiting a critical breakdown potential or showing any evidence of pitting attack. For the three Al samples, addition of ClO4 − ions to the sulphate solution stimulates their active anodic dissolution and tends to induce pitting corrosion within the oxide passive region. Pitting corrosion was confirmed by SEM examination of the electrode surface. The pitting potential decreases with increasing ClO4 − ion concentration indicating a decrease in pitting corrosion resistance. The susceptibility of the three Al samples towards pitting corrosion decreases in the order: Al>(Al+2.5wt% Cu) alloy>(Al+7wt% Cu) alloy. Potentiostatic measurements showed that the rate of pitting initiation increases with increasing ClO4 − ion concentration and applied step anodic potential, while it decreases with increasing %Cu in the Al samples. The inhibitive effect of SO4 2− ions was also discussed. [Copyright &y& Elsevier]

Aims: Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity that is partly explained by the diversity of genetic variants contributing to disease. Accurate interpretation of these variants constitutes a major challenge for diagnosis and implementing precision medicine, especially in understudied populations. The aim is to define the genetic architecture of HCM in North African cohorts with high consanguinity using ancestry-matched cases and controls., Methods and Results: Prospective Egyptian patients (n = 514) and controls (n = 400) underwent clinical phenotyping and genetic testing. Rare variants in 13 validated HCM genes were classified according to standard clinical guidelines and compared with a prospective HCM cohort of majority European ancestry (n = 684). A higher prevalence of homozygous variants was observed in Egyptian patients (4.1% vs. 0.1%, P = 2 × 10-7), with variants in the minor HCM genes MYL2, MYL3, and CSRP3 more likely to present in homozygosity than the major genes, suggesting these variants are less penetrant in heterozygosity. Biallelic variants in the recessive HCM gene TRIM63 were detected in 2.1% of patients (five-fold greater than European patients), highlighting the importance of recessive inheritance in consanguineous populations. Finally, rare variants in Egyptian HCM patients were less likely to be classified as (likely) pathogenic compared with Europeans (40.8% vs. 61.6%, P = 1.6 × 10-5) due to the underrepresentation of Middle Eastern populations in current reference resources. This proportion increased to 53.3% after incorporating methods that leverage new ancestry-matched controls presented here., Conclusion: Studying consanguineous populations reveals novel insights with relevance to genetic testing and our understanding of the genetic architecture of HCM., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.)

Child fireplay may be regarded as developmentally appropriate, yet can negatively impact those who engage in it and those around them. This study discusses the mental health, fire-specific, and psychosocial risk factors of children who set fires. Fifty-seven caregivers reported on their children's demographics, firesetting behaviors, mental health symptoms, and family history. Children were aged 2-6 years and the majority were male. Most children used lighters and matches on paper and small objects. The majority of the children were motivated by curiosity. Children who set more fires had more externalizing symptoms, and were more likely to have accomplices, to have been exposed to firesetting media, and to have been disciplined or punished for their firesetting behaviors. The study identifies important psychosocial risk factors among young children who set fires. Given the long-term implications of firesetting, understanding firesetting in children will set the foundation of intervention and prevention models., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.)